Abstract：OBJECTIVE To explore the necessity and feasibility of organic combination of the national drug sampling and testing for quality evaluation and national drug standards improvement. METHODS Through analysis of the similarities and differences of the two working modes and their complementarity, the problems that may arise in the connection of work were identified. The mechanism and counter measures to promote the organic combination of the two working modes were put forward. RESULT AND CONCLUSION It was suggested that a communication mechanism should be established in time to strengthen the connection and interaction between the national drug sampling and testing for quality evaluation and national drug standard improvement, thus to avoid wasting resources and timely translate feasible suggestions into national drug standards.
朱嘉亮, 陈蕾, 朱炯. 国家药品评价抽检与标准提高有机结合的机制探讨[J]. 中国药学杂志, 2020, 55(18): 1548-1552.
ZHU Jia-liang, CHEN Lei, ZHU Jiong. A Discussion About the Organic Combination of National Drug Sampling and Testing for Quality Evaluation and National Drug Standards Improvement. Chinese Pharmaceutical Journal, 2020, 55(18): 1548-1552.
ZHAO J F, HONG X X, ZHANG W, et al. Reflections on the improvement of national drug standards[J]. Chin J Mod Appl Pharm(中国现代应用药学), 2019, 36(8): 997-1000.
[2]
ZHU J L, YANG X, LI Z Y, et al. Development and prospect on the marketed drug sampling and testing for quality evaluation[J]. Chin New Drugs J(中国新药杂志), 2015, 24(16): 1810-1815.
[3]
JIN S H, SU X L. Practice and prospect of drug quality surveillancein China[J]. Drug Eval(药品评价), 2010, 7(10):24-27.
[4]
ZHU J, LIU Y, HE L. The role of national quality evaluation in enhancing thequality of chemical antiviral drugs[J]. Chin New Drugs J(中国新药杂志), 2018, 27(13):1460-1464.
[5]
NIFDC. Annual Report of Medicine Post Market Quality Surveillance(2018)[EB/OL]. [2019-08-07]. https://www.nifdc.org.cn/nifdc/fwzn/ypchytsxyj/20190807101035.html.
[6]
NIFDC. Exploratory research on national drug sampling and testing(fifth period)[EB/OL]. [2019-05-17]. https://www.nifdc.org.cn/nifdc/fwzn/ypchytsxyj/gjypcjtsxyj/20190517091800.html.
[7]
NIFDC. Exploratory research on national drug sampling and testing(third period)[EB/OL]. [2018-04-26]. https://www.nifdc.org.cn/nifdc/fwzn/ypchytsxyj/gjypcjtsxyj/10978.html.
[8]
NIFDC. Exploratory research on national drug sampling and testing(fouth period)[EB/OL]. [2018-12-12]. https://www.nifdc.org.cn/nifdc/fwzn/ypchytsxyj/gjypcjtsxyj/11842.html.
[9]
Notice of the State Council on Issuing the National Food and Drug Safety "Eleventh Five-Year Plan" [EB/OL]. [2007-04-07]. http://www.gov.cn/zwgk/2007-06/05/content_637391.htm.
[10]
Notice of the State Council on Issuing the National Food and Drug Safety "Twelfth Five-Year Plan" [EB/OL]. [2012-01-20]. http://www.gov.cn/gongbao/content/2012/content_2068275.htm.
[11]
Notice of the State Council on Issuing the National Food and Drug Safety "Thirteenth Five-Year Plan" [EB/OL]. [2017-02-14]. http://www.gov.cn/zhengce/content/2017-02/21/content_5169755.htm.
[12]
YU J Y, QIAN Z Z. Elaboration of the reform and optimization national drug standards formation mechanisms[J]. Drug Stand China(中国药品标准), 2013, 14(5): 323-326.
[13]
HE Y M,YANG P R, REN S L, et al. Discussion on drug supervision and management from the perspective of drug quality standards[J]. Chin Pharm Aff(中国药事), 2018, 32(12): 1596-1602.
[14]
ZHANG X T, LI J L, CHEN L. Project management research of national drug sampling and testing[J]. China Pharm(中国药业), 2012, 21(12): 4.
[15]
GAO Z F,XIANG X H, ZHU J. Research on the applicability of drug quality standards in national drug sampling and testing[J]. Chin Pharm J(中国药学杂志), 2019,54(3):240-244.
[16]
NIE L X, ZHANG Y, DAI Z, et al. Promoting effect of ational drug evaluation and sampling on the improvement of Chinese medicine standards[J]. China Pharm(中国药业), 2013, 22(22): 2-3.
[17]
CHEN L, ZHU J L, CUI E X, et al. Analysis and prospect on sampling test management of national essential medicine[J]. J China Pharm(中国药房), 2017, 28(27):3745-3748.
2020, Vol. 55 
